The biosensors market in the United States is expected to reach a projected revenue of US$ 21,785.1 million by 2033. A compound annual growth rate of 8.79% is expected of the United States biosensors market from 2026 to 2033.
The U.S. biosensors market generated a revenue of USD 11,240.0 million in 2025 and is expected to reach USD 21,785.1 million by 2033.
The U.S. market is expected to grow at a CAGR of 8.79% from 2026 to 2033.
In terms of segment, electrochemical was the largest revenue generating technology in 2025.
Optical is the most lucrative technology segment registering the fastest growth during the forecast period.
Biosensors market data book summary
Market revenue in 2025
USD 11,240.0 million
Market revenue in 2033
USD 21,785.1 million
Growth rate
8.79% (CAGR from 2026 to 2033)
Largest segment
Electrochemical
Fastest growing segment
Optical
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Thermal, Electrochemical, Piezoeletric, Optical
Key market players worldwide
Bio-Rad Laboratories Inc, Medtronic PLC, Abbott Laboratories, Biosensors, Pinnacle Financial Partners Inc, DuPont Nutrition & Biosciences, Johnson & Johnson, Koninklijke Philips NV, Nova Biomedical, Koch Industries, TDK Corp, Siemens AG
Other key industry trends
In terms of revenue, U.S. accounted for 34.9% of the global biosensors market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In North America, U.S. biosensors market is projected to lead the regional market in terms of revenue in 2033.
Canada is the fastest growing regional market in North America and is projected to reach USD 3,558.0 million by 2033.
The U.S. held the largest market share in North America of over 40.00% in 2020.Furthermore, the recent outbreak of COVID-19 has positively impacted the biosensors market to a great extent. Many players operating in this market are introducing advanced products for detecting COVID-19.
For instance, SD Biosensor, INC. introduced STANDARD Q COVID-19 IgM/IgG Duo for the detection of SARS-CoV-2 in April 2020. The product is ideal for Point of Care (PoC) testing and allows rapid detection within 10 minutes. Therefore, such initiatives are anticipated to propel the demand for biosensors, thereby fueling the market growth over the forecast period.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biosensors Market Outlook will help companies and investors design strategic landscapes.
Electrochemical was the largest segment with a revenue share of 77.52% in 2025.
Horizon Databook has segmented the U.S. biosensors market based on thermal, electrochemical, piezoeletric, optical covering the revenue growth of each sub-segment from 2021 to 2033.
The U.S. held the largest market share in North America of over 40.00% in 2020.Furthermore, the recent outbreak of COVID-19 has positively impacted the biosensors market to a great extent. Many players operating in this market are introducing advanced products for detecting COVID-19.
For instance, SD Biosensor, INC. introduced STANDARD Q COVID-19 IgM/IgG Duo for the detection of SARS-CoV-2 in April 2020. The product is ideal for Point of Care (PoC) testing and allows rapid detection within 10 minutes. Therefore, such initiatives are anticipated to propel the demand for biosensors, thereby fueling the market growth over the forecast period.
U.S. Biosensors Market Technology Outlook (Revenue, USD Million , 2021-2033)
Thermal
Electrochemical
Piezoeletric
Optical
U.S. Biosensors Market Application Outlook (Revenue, USD Million , 2021-2033)
Medical
Food Toxicity
Bioreactor
Agriculture
Environment
Others
U.S. Biosensors Market End Use Outlook (Revenue, USD Million , 2021-2033)
Home healthcare diagnostics
PoC testing
Food industry
Research Laboratories
Security and Bio-defense
Reasons to subscribe to Biosensors Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biosensors Market Outlook databook
Our clientele includes a mix of Biosensors Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Biosensors Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Biosensors Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.